` 246710 (T&R Biofab Co Ltd) vs KOSPI 200 Comparison - Alpha Spread

T
246710
vs
K
KOSPI 200

Over the past 12 months, T&R Biofab Co Ltd has underperformed KOSPI 200, delivering a return of -8% compared to the KOSPI 200's +117% growth.

Stocks Performance
246710 vs KOSPI 200

Loading
246710
KOSPI 200
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
246710 vs KOSPI 200

Loading
246710
KOSPI 200
Difference
www.alphaspread.com

Performance By Year
246710 vs KOSPI 200

Loading
246710
KOSPI 200
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
T&R Biofab Co Ltd vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

T&R Biofab Co Ltd
Glance View

Market Cap
151.7B KRW
Industry
Health Care

T&R Biofab Co., Ltd engages in the manufacture and sale of biomedical equipment. The company is headquartered in Siheung, Gyeonggi-Do and currently employs 86 full-time employees. The company went IPO on 2018-11-28. The bioresorbable scaffolds are sold under the name of T&R mesh and T&R Dental Mesh. In addition, the Company is involved in the production and sale of three Dimensions (3D) biodegradable polymer printing system, bioinks, 3D organoid and 3D cell therapies, among others. The bioinks are sold under the name of deCelluid. The firm distributes its products within the domestic market and to overseas markets.

Intrinsic Value
1 575.4 KRW
Overvaluation 51%
Intrinsic Value
Price ₩3 190
T
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett